Abstract
Chronic kidney disease is a global public health problem and is associated with an increased risk of serious cardiovascular events and mortality. Since Portugal is one of the European countries with the highest incidence of this pathology, we emphasize the importance of promoting the increase of notoriety of this problem with the health authorities, the health professionals and the scientific community. We present a few recommendations that we consider relevant for the better management of this problematic in our country, namely the promotion of communication between different medical specialties, healthcare organization, and we mention others that may play an important role in the future pharmacotherapy approach, such as sodium–glucose cotransporter 2 inhibitors to reduce morbidity and mortality of this population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
